JD HEALTH
06618
JD-SW
09618
BEKE-W
02423
TRIP.COM-S
09961
NTES-S
09999
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash and short-term funds | 404.65%107.23B | 133.33%69.44B | -30.35%21.25B | -19.20%29.76B | 14.16%30.51B | 5.26%36.83B | 1.04%26.72B | 62.54%34.99B | 36.48%26.45B | -8.38%21.53B |
Financial assets at fair value | 3.54%174.32M | 18.63%156.47M | 26.03%168.36M | -15.63%131.89M | -29.00%133.58M | -27.91%156.33M | -75.13%188.15M | 45.77%216.86M | 102.22%756.44M | -92.25%148.77M |
Assets to be sold | ---- | ---- | ---- | --364.58M | -33.49%887.63M | ---- | --1.33B | ---- | ---- | 19.69%1.59B |
Buying back the sale of financial assets | --5.99B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Derivative financial assets | -34.31%531.93M | -19.61%675.9M | 67.53%809.71M | 788.52%840.78M | 692.67%483.31M | -71.18%94.63M | 463.73%60.97M | 912.46%328.29M | 19.45%10.82M | -12.07%32.43M |
Fixed assets | 7.30%124.73B | 11.37%118.64B | 11.30%116.24B | 14.75%106.52B | 24.65%104.44B | 20.42%92.83B | 9.08%83.79B | 5.23%77.09B | 18.26%76.81B | 16.22%73.26B |
Investment property | -1.72%1.09B | 4.57%1.09B | 25.56%1.11B | 15.22%1.04B | -14.33%881.7M | -13.05%904.31M | 4.88%1.03B | 5.01%1.04B | -7.14%981.23M | -7.89%990.37M |
Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --851K | ---- |
Deferred tax assets | 9.71%2.22B | 16.42%2.13B | 7.16%2.02B | 9.33%1.83B | 36.47%1.88B | 25.85%1.67B | -19.67%1.38B | -6.86%1.33B | 33.29%1.72B | 31.31%1.43B |
Other assets | 60.31%6.88B | 28.37%5.24B | 4.56%4.29B | -1.49%4.08B | 10.56%4.1B | 23.17%4.14B | 7.23%3.71B | 4.05%3.36B | 10.43%3.46B | 46.29%3.23B |
Special items of assets | 3.13%223.37B | 0.29%209.14B | 6.40%216.59B | 2.18%208.53B | 6.47%203.57B | 11.01%204.08B | 10.38%191.2B | 15.99%183.83B | 15.92%173.22B | 10.92%158.49B |
Total assets | 32.27%481.44B | 15.50%409.69B | 4.59%363.99B | 3.77%354.72B | 11.72%348.02B | 12.70%341.84B | 9.69%311.52B | 16.08%303.33B | 18.24%284B | 9.76%261.3B |
Liabilities | ||||||||||
Tax payable | -60.26%169.27M | -41.93%446.64M | -0.11%425.96M | 106.49%769.12M | 107.56%426.41M | 8.90%372.47M | -49.18%205.44M | -40.68%342.02M | 20.34%404.28M | 30.87%576.57M |
Bonds issued | -20.95%28.37B | -12.71%32.19B | -23.48%35.88B | -18.14%36.87B | -9.72%46.89B | -2.54%45.05B | 15.57%51.94B | 7.97%46.22B | -3.96%44.94B | 10.92%42.81B |
Derivative financial liability | 79.60%811.42M | 770.94%246.33M | 484.00%451.8M | -95.09%28.28M | -92.05%77.36M | -59.29%576.5M | -49.07%973.45M | 79.44%1.42B | 124.95%1.91B | 179.16%789.22M |
Financial assets sold for repurchase | ---- | 494.74%2.56B | 39.09%1.31B | --429.91M | -48.65%940M | ---- | 206.65%1.83B | ---- | --597M | ---- |
Deferred tax liability | -9.89%848.06M | -28.06%1.11B | -29.94%941.13M | -15.43%1.54B | 37.48%1.34B | 140.47%1.82B | 30.19%977.03M | -8.41%757.76M | 9.00%750.48M | 34.73%827.33M |
Other accounts and preparations | -26.39%22.9B | 21.28%27.01B | 56.80%31.11B | 32.61%22.27B | 28.48%19.84B | 2.82%16.79B | -6.35%15.44B | 4.96%16.33B | 4.20%16.49B | -0.34%15.56B |
Special items of liabilities | 51.28%390.49B | 19.46%308.67B | 4.92%258.12B | 4.63%258.38B | 15.94%246.02B | 16.80%246.95B | 9.63%212.2B | 21.21%211.43B | 27.57%193.55B | 10.80%174.44B |
Total liabilities | 35.14%443.76B | 16.22%372.41B | 4.02%328.38B | 2.79%320.43B | 11.26%315.7B | 12.66%311.73B | 9.46%283.76B | 17.43%276.7B | 19.90%259.24B | 10.18%235.63B |
Total assets less total liabilities | 5.81%37.67B | 8.75%37.28B | 10.18%35.6B | 13.87%34.28B | 16.41%32.31B | 13.06%30.11B | 12.13%27.76B | 3.74%26.63B | 3.24%24.76B | 6.06%25.67B |
Equity | ||||||||||
Share capital | 0.00%12.64B | 0.00%12.64B | 0.00%12.64B | 0.00%12.64B | 0.00%12.64B | 0.00%12.64B | 0.00%12.64B | 0.00%12.64B | 0.00%12.64B | 0.00%12.64B |
Capital reserves | 0.00%2.42B | 0.00%2.42B | 0.00%2.42B | 0.00%2.42B | 0.00%2.42B | 0.00%2.42B | 0.00%2.42B | 0.00%2.42B | 0.00%2.42B | 0.00%2.42B |
Exchange reserve | -17.86%764.71M | 31.74%667.89M | 356.28%930.93M | 249.65%506.97M | 191.37%204.03M | -79.66%-338.77M | -154.51%-223.29M | -164.22%-188.57M | 66.61%409.59M | 69.56%293.65M |
Other reserve | -92.42%48.34M | -44.12%389.24M | 47.72%637.97M | 251.46%696.59M | 153.13%431.88M | 59.86%-459.91M | 48.84%-812.94M | -78.49%-1.15B | -124.65%-1.59B | -261.28%-641.99M |
Hold profit | 14.36%13.93B | 18.42%13.29B | 17.34%12.18B | 16.84%11.23B | 25.69%10.38B | 29.36%9.61B | 30.50%8.26B | 15.84%7.43B | 18.60%6.33B | 25.63%6.41B |
Special items of shareholders' equity | 15.86%7.87B | 15.86%7.87B | 8.92%6.79B | 8.92%6.79B | 13.90%6.24B | 13.90%6.24B | 20.47%5.47B | 20.47%5.47B | 12.41%4.54B | 12.41%4.54B |
Shareholders' equity | 5.81%37.67B | 8.75%37.28B | 10.18%35.6B | 13.87%34.28B | 16.41%32.31B | 13.06%30.11B | 12.13%27.76B | 3.74%26.63B | 3.24%24.76B | 6.06%25.67B |
Total equity | 5.81%37.67B | 8.75%37.28B | 10.18%35.6B | 13.87%34.28B | 16.41%32.31B | 13.06%30.11B | 12.13%27.76B | 3.74%26.63B | 3.24%24.76B | 6.06%25.67B |
Total equity and total liabilities | 32.27%481.44B | 15.50%409.69B | 4.59%363.99B | 3.77%354.72B | 11.72%348.02B | 12.70%341.84B | 9.69%311.52B | 16.08%303.33B | 18.24%284B | 9.76%261.3B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.